Abstract

Osteoarthritis (OA) is characterised by progressive destruction of articular cartilage and chondrocyte cell death. Here, we show the expression of the endogenous peptide urocortin1 (Ucn1) and two receptor subtypes, CRF-R1 and CRF-R2, in primary human articular chondrocytes (AC) and demonstrate its role as an autocrine/paracrine pro-survival factor. This effect could only be removed using the CRF-R1 selective antagonist CP-154526, suggesting Ucn1 acts through CRF-R1 when promoting chondrocyte survival. This cell death was characterised by an increase in p53 expression, and cleavage of caspase 9 and 3. Antagonism of CRF-R1 with CP-154526 caused an accumulation of intracellular calcium (Ca2+) over time and cell death. These effects could be prevented with the non-selective cation channel blocker Gadolinium (Gd3+). Therefore, opening of a non-selective cation channel causes cell death and Ucn1 maintains this channel in a closed conformation. This channel was identified to be the mechanosensitive channel Piezo1. We go on to determine that this channel inhibition by Ucn1 is mediated initially by an increase in cyclic adenosine monophosphate (cAMP) and a subsequent inactivation of phospholipase A2 (PLA2), whose metabolites are known to modulate ion channels. Knowledge of these novel pathways may present opportunities for interventions that could abrogate the progression of OA.

Highlights

  • Articular cartilage is the dense connective tissue that lines the surfaces of diarthrodial joints providing a low-friction surface for joint loading and articulation

  • We have recently demonstrated the expression in the human chondrocyte cell line C-20/A4 of the corticotropin-releasing factor (CRF)-related peptide urocortin 1 (Ucn1)

  • Analysis confirmed that Ucn[1] itself and both the CRF-R1 and CRF-R2 receptors were expressed in articular chondrocytes (AC) (Fig. 1)

Read more

Summary

Introduction

Articular cartilage is the dense connective tissue that lines the surfaces of diarthrodial joints providing a low-friction surface for joint loading and articulation. The only treatments for OA are steroidal and non-steroidal anti-inflammatory drugs, or in severe cases total joint replacement surgery[6] These strategies only ameliorate symptoms and do not address the underlying pathology, namely chondrocyte death. We have recently demonstrated the expression in the human chondrocyte cell line C-20/A4 of the corticotropin-releasing factor (CRF)-related peptide urocortin 1 (Ucn[1]). In the male reproductive system, the reported regulation of spermatogenesis by Ucn[1] has been demonstrated to involve T-type Ca2+ channels[28], whereas the osteoclast inhibitory effect of Ucn[1] involves regulation of Ca2+ ions by inhibition of a TRPC1-like cation current[18]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call